Charles River Laboratories International (NYSE:CRL – Get Free Report) was downgraded by equities research analysts at William ...

Wilmington, Massachusetts-based Charles River Laboratories International, Inc. (CRL) provides drug discovery, non-clinical ...

Analysts have recently evaluated Charles River and provided 12-month price targets. The average target is $214.5, accompanied by a high estimate of $250.00 and a low estimate of $185.00. A 2.72% drop ...

Emkay Global Financial is bearish on Dr Reddys recommended sell rating on the stock with a target price of Rs 1150 in its ...

Extending losses for the second session, Dr Reddy’s shares dropped 6.65% to hit a low of ₹1,203.60 on the BSE as investors weighed weak Q3 results.

A South Auckland train station, that had pedestrian level crossings removed to improve safety, is now ready for more frequent train services when the City Rail Link opens.

Life sciences stocks were in retreat Thursday after the news outlet Science reported that newly imposed restrictions on the National Institutes of Health by the Trump administration have stoked ...

Dr. Reddy's shares are the top losers on the Nifty 50 index today. Out of the 40 analysts that have coverage on Dr. Reddy's, ...

The Kerala High Court has asked the investigating officers to be extra cautious while implicating doctors as accused for ...

The Court clarified that the bail applications of the co-accused should not be decided relying on the bail granted to Darshan ...